ATE312914T1 - Rdgb-proteine - Google Patents
Rdgb-proteineInfo
- Publication number
- ATE312914T1 ATE312914T1 AT97945311T AT97945311T ATE312914T1 AT E312914 T1 ATE312914 T1 AT E312914T1 AT 97945311 T AT97945311 T AT 97945311T AT 97945311 T AT97945311 T AT 97945311T AT E312914 T1 ATE312914 T1 AT E312914T1
- Authority
- AT
- Austria
- Prior art keywords
- rdgb
- features
- proteins
- diseases
- signal transduction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
- C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
- C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Insects & Arthropods (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Power Conversion In General (AREA)
- Amplifiers (AREA)
- Bipolar Transistors (AREA)
- Soft Magnetic Materials (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2733796P | 1996-10-11 | 1996-10-11 | |
| PCT/US1997/017374 WO1998016639A1 (en) | 1996-10-11 | 1997-09-26 | Rdgb-proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312914T1 true ATE312914T1 (de) | 2005-12-15 |
Family
ID=21837130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97945311T ATE312914T1 (de) | 1996-10-11 | 1997-09-26 | Rdgb-proteine |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6117673A (de) |
| EP (1) | EP0931146B1 (de) |
| AT (1) | ATE312914T1 (de) |
| AU (1) | AU4654097A (de) |
| CA (1) | CA2268034A1 (de) |
| DE (1) | DE69734890T2 (de) |
| ES (1) | ES2262195T3 (de) |
| WO (1) | WO1998016639A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1344400A (en) * | 1998-11-18 | 2000-06-05 | Incyte Pharmaceuticals, Inc. | Inflammation-associated genes |
| EP1141722A1 (de) * | 1998-12-31 | 2001-10-10 | Sugen, Inc. | Pyk2 (raftk) und entzündung |
| EP1630559A3 (de) * | 1998-12-30 | 2006-06-07 | Sugen, Inc. | PYK2 (RAFTK) und Entzündung |
| US6861442B1 (en) | 1998-12-30 | 2005-03-01 | Sugen, Inc. | PYK2 and inflammation |
| EP1157104A2 (de) * | 1999-02-22 | 2001-11-28 | Sugen, Inc. | Pyk2-bindende proteine |
| CN1324836A (zh) * | 2000-05-19 | 2001-12-05 | 上海博德基因开发有限公司 | 一种新的多肽——视网膜结合位点12和编码这种多肽的多核苷酸 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837815A (en) * | 1994-12-15 | 1998-11-17 | Sugen, Inc. | PYK2 related polypeptide products |
-
1997
- 1997-09-26 US US08/938,291 patent/US6117673A/en not_active Expired - Fee Related
- 1997-09-26 CA CA002268034A patent/CA2268034A1/en not_active Abandoned
- 1997-09-26 ES ES97945311T patent/ES2262195T3/es not_active Expired - Lifetime
- 1997-09-26 WO PCT/US1997/017374 patent/WO1998016639A1/en not_active Ceased
- 1997-09-26 EP EP97945311A patent/EP0931146B1/de not_active Expired - Lifetime
- 1997-09-26 AT AT97945311T patent/ATE312914T1/de not_active IP Right Cessation
- 1997-09-26 AU AU46540/97A patent/AU4654097A/en not_active Abandoned
- 1997-09-26 DE DE69734890T patent/DE69734890T2/de not_active Expired - Fee Related
-
2000
- 2000-06-07 US US09/589,619 patent/US6576442B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU4654097A (en) | 1998-05-11 |
| EP0931146A1 (de) | 1999-07-28 |
| US6117673A (en) | 2000-09-12 |
| US6576442B1 (en) | 2003-06-10 |
| EP0931146B1 (de) | 2005-12-14 |
| DE69734890T2 (de) | 2006-08-24 |
| CA2268034A1 (en) | 1998-04-23 |
| WO1998016639A1 (en) | 1998-04-23 |
| ES2262195T3 (es) | 2006-11-16 |
| DE69734890D1 (de) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1361229A3 (de) | Verwendung von Tyrosine Kinase (PYK2) zur Produktion von Antikörper | |
| PT948604E (pt) | Produtos e metodos relacionados com pyk2 | |
| PT868519E (pt) | Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2 | |
| ATE408422T1 (de) | Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten | |
| ATE182180T1 (de) | Lamanin-ketten: diagnostische und therapeutische verwendung | |
| CY1105446T1 (el) | Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2 | |
| DE69117949D1 (de) | Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis | |
| SE8902532D0 (sv) | Bestaemning av plasmaproteiner | |
| ATE240743T1 (de) | Verfahren und substanzen gegen protozoen | |
| ATE168135T1 (de) | Diagnose von retinoblastoma | |
| WO2000034511A3 (de) | Peptid screening test zum nachweis von ass | |
| AU1855401A (en) | Screening method for candidate drugs | |
| DE69433243D1 (de) | Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit | |
| DE69734890D1 (de) | Rdgb-proteine | |
| NO963487L (no) | Isolerte, tyrosinaseavledete peptider, samt anvendelser derav | |
| ATE517629T1 (de) | Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems | |
| DK0870036T3 (da) | Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor | |
| MXPA02000293A (es) | Isoformas de la amp ciclico fosfodiesterasa y metodos de uso. | |
| DE3882411D1 (de) | Verfahren zur trennung von aktiviertem menschlichem protein c. | |
| DE69930545D1 (de) | Verfahren zur diagnose und behandlung neurologischer erkrankungen | |
| WO1998045408A3 (en) | Novel ectoparasite saliva proteins and apparatus to collect such proteins | |
| WO2003023048A3 (en) | METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) | |
| ATE247467T1 (de) | Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |